Si–Yi Chen

A safe and potent anti-CD19 CAR T cell therapy

Zhitao Ying, Xue F. Huang, Yanling Liu et al. · Nature Medicine · 2019 · 447 citations · Full text

Life Sciences, Cell Biology, Immunology +10

An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses

Guan Wang, Xi Kang, Katherine Chen et al. · Nature Communications · 2020 · 218 citations · Full text

Medicine, Immunology, Oncology +17

CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo

Natalia Lapteva, Angang Yang, Denise E Sanders et al. · Cancer Gene Therapy · 2004 · 166 citations

Life Sciences, Molecular Biology, Oncology +12

c-Myc-Mediated Epigenetic Silencing of MicroRNA-101 Contributes to Dysregulation of Multiple Pathways in Hepatocellular Carcinoma

Lei Wang, Xiang Zhang, Lintao Jia et al. · Hepatology · 2013 · 163 citations

Medicine, Cancer Biology, Molecular Biology +17

A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell–mediated suppression

Xiao‐Tong Song, Kevin Evel-Kabler, Lei Shen et al. · Nature Medicine · 2008 · 161 citations

Life Sciences, Immunology, Molecular Biology +13